Use of Hand-held Dynamometry to Obtain Objective Measures of Lower Extremity Force Production With Chronic Stroke

Use of Hand-held Dynamometry to Obtain Objective Measures of Lower Extremity Rate of Peak Force Production, Cumulative Peak Force Production, and Sustained Peak Force Production Among Patients With Chronic Stroke

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05941962

Enrollment

Registered

2023-07-12

Start date

2023-06-05

Completion date

2025-07-26

Last updated

2026-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Stroke, Weakness, Muscle

Brief summary

This study wants to know if using handheld dynamometry (HHD) to test leg strength in persons who have had a stroke, will reduce mistakes and give therapists better information to use for therapy. This study will collect normal values of leg muscle peak force production, cumulative peak force production, and sustained peak force production in patients with chronic stroke.

Detailed description

The Activbody Activ5 device will be used for data collection with all information logged and stored through the device's app and transferred to secure files. Assessment of isometric muscle strength and power will be performed as follows: * Hip flexors with the participant seated and hips and knees flexed at 90 degrees * Knee extensors with the participant seated and hips and knees flexed at 90 degrees * Knee flexors with the participant seated and hips and knees flexed at 90 degrees * Ankle plantarflexors with the participant lying supine with the ankle in plantargrade and hips and knees extended * Ankle dorsiflexors with the participant lying supine with the ankle relaxed and hips and knees extended * Hip abductors with the participant lying supine and hips and knees extended * Hip adductors with the participant lying supine and hips and knees extended * Hip extensors with the participant lying prone and hips and knees extended 1 session, two trials per side

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age 18 years or older * Stroke \> 3 months * Ability to follow two-step commands * Ability to assume all test positions and maintain for duration of testing (i.e. upright seated, prone, side lying, supine)

Exclusion criteria

* Lower extremity contractures preventing full passive range of motion (ROM) * Vital signs contraindicated for exercise (i.e. resting heart rate \> 100 bpm \< 50 bpm, resting systolic blood pressure \> 200 mmHg or \< 90 mmHg, resting diastolic blood pressure \> 110 mmHg, oxygen saturation \< 90%) * Symptoms contraindicated for testing (i.e. shortness of breath, angina, dizziness, severe headache, sudden onset of numbness or weakness, painful calf suggestive of deep vein thrombosis) * Active infection and/or injury at location of testing site * Other diagnosed co-morbidities that would impact physical participation

Design outcomes

Primary

Measure	Time frame	Description
Hand-held Dynamometry Measurement of Average Force Production	1 year	Average force production of lower extremity isometric strength measured in pounds (lb)

Secondary

Measure	Time frame	Description
Hand-held Dynamometry Measurement of Peak Force Production	1 year	Peak force production of lower extremity isometric strength measured in pounds (lb)

Countries

United States

Outcome results